RTICBM-74 is a brain-penetrant CB1 receptor allosteric modulator that reduces alcohol intake in rats
January 7, 2022
The present works shows that a newly developed negative allosteric modulator of the cannabinoid receptor subtype 1 (CB1) receptor with an excellent pharmacokinetic profile reduces alcohol drinking in rats, suggesting potential therapeutic relevance for the treatment of alcohol use disorder.